Composition with added furazolidone tablets for treating dysentery

A technology of furazolidone tablet and composition, applied in the field of traditional Chinese medicine, can solve the problems of high hazard, recurrence and high mortality of dysentery, and achieve the effects of no adverse reactions, no toxic side effects, and improvement of high fever

Inactive Publication Date: 2017-01-25
成都特兰辰亚生物科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Combining the above-mentioned clinical manifestations of Chinese and Western medicine, dysentery is very harmful. There are amoebic dysentery, bacillary dysentery, and bacillary dysentery can be divided into common type, toxic, and toxic bacillary dysentery. The condition is dangerous and the mortality rate is high. Dysentery can be controlled quickly through timely treatment, but it must be completely cured, otherwise it will become chronic, which will increase the difficulty of treatment and often recur. The medicine completely cured dysentery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition with added furazolidone tablets for treating dysentery
  • Composition with added furazolidone tablets for treating dysentery

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] This embodiment provides a composition for treating dysentery with furazolidone tablets added. In parts by weight, the composition includes: western medicine component: 0.1 part of furazolidone tablet; 6 parts, 10 parts of Yunling, 10 parts of Codonopsis, 4 parts of Schisandra, 4 parts of Zhigancao, 12 parts of Snakeberry, 13 parts of Pteris, and 8 parts of Artemisia stifolium.

[0031] The specific preparation method of medicine comprises the following steps:

[0032] (1) Weigh 30g of kudzu root, 25g of pulsatilla, 15g of paeonol, 25g of Yunling, 25g of codonopsis, 10g of schisandra, 10g of roasted licorice, 30g of snakeberry, 33g of phoenix grass, 20g of stinky artemisia, mix them evenly, and then use 30 Soak the traditional Chinese medicine mixture in warm water at -50°C for 20-30 minutes, and then soak the two horizontal fingers of the medicinal surface in water to obtain soaking material A before frying;

[0033] (2) Decoct the soaked material A before frying for ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a composition with added furazolidone tablets for treating dysentery. The composition comprises, by weight, 0.1-0.2 part of the furazolidone tablets and traditional Chinese medicine components. The traditional Chinese medicine components comprise, by weight, 8-14 parts of radix puerariae, 7-13 parts of radix pulsatillae, 4-8 parts of cortex moutan, 7-12 parts of poria, 8-13 parts of radix codonopsis, 2-6 parts of fructus schisandrae chinensis and 2-6 parts of radix glycyrrhizae preparata. The composition has the advantages that the furazolidone tablets are added into the composition on the basis of conventional traditional Chinese medicine treatment, accordingly, obvious effects of treating the dysentery can be realized, and typical symptoms such as high fever, abdominal pain, diarrhea and vomiting can be obviously improved in 1-2 days; the obvious effects can be realized in 3-5 days, and the dysentery can be generally cured in a week approximately; the composition is basically free of toxic and side effects on human bodies and is free of adverse reaction.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a composition added with furazolidone tablets for treating dysentery. Background technique [0002] Western medicine clinical manifestations of dysentery: [0003] Dysentery is a common intestinal infectious disease mainly caused by diarrhea. Occur in summer and autumn, more common in young adults. The disease is mainly caused by oral infection through contaminated food. Contaminated hands, flies, cockroaches, etc. can carry pathogens and spread diseases. Water pollution can cause epidemics, and eating raw vegetables and fruits polluted by humans can also easily cause disease. (1) Acute bacillary dysentery is divided into 4 types according to clinical manifestations, namely common type, light type, severe type and toxic type. ①Common type: Acute onset, body temperature reaches 39°C-40°C, accompanied by nausea, vomiting, abdominal pain, and diarrhea. St...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/79A61K36/71A61P1/12A61P31/04A61K31/422
CPCA61K31/422A61K36/076A61K36/11A61K36/28A61K36/344A61K36/484A61K36/488A61K36/57A61K36/65A61K36/71A61K36/73A61K36/79A61K2300/00Y02A50/30
Inventor 李会玲
Owner 成都特兰辰亚生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap